KARAN WADHWA¹, PAYAL CHAUHAN¹, SHOBHIT KUMAR², RAKESH PAHWA^3,*, RAVINDER VERMA⁴, RAJAT GOYAL⁵, GOVIND SINGH¹, ARCHANA SHARMA⁶, NEHA RAO³, DEEPAK KAUSHIK^1,*

Oncology Research, Vol.32, No.5, pp. 877-897, 2024, DOI:10.32604/or.2024.047278 - 23 April 2024

Abstract Background: Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises from the presence of the blood-brain barrier (BBB) and stem cells around GBM, which avert the entry of chemotherapeutic drugs into the tumor mass. Objective: Recently, several researchers have designed novel nanocarrier systems like liposomes, dendrimers, metallic nanoparticles, nanodiamonds, and nanorobot approaches, allowing drugs to infiltrate the BBB more efficiently, opening up innovative avenues to prevail over therapy problems and radiation therapy. Methods: Relevant literature for this manuscript has been collected from a comprehensive More > Graphic Abstract

ABHISHEK WAHI¹, MAMTA BISHNOI², NEHA RAINA¹, MEGHNA AMRITA SINGH¹, PIYUSH VERMA¹, PIYUSH KUMAR GUPTA^3,4, GINPREET KAUR⁵, HARDEEP SINGH TULI^6,*, MADHU GUPTA^1,*

Oncology Research, Vol.32, No.1, pp. 19-47, 2024, DOI:10.32604/or.2023.042228 - 15 November 2023

Abstract Cancer is a leading cause of death globally, with limited treatment options and several limitations. Chemotherapeutic agents often result in toxicity which long-term conventional treatment. Phytochemicals are natural constituents that are more effective in treating various diseases with less toxicity than the chemotherapeutic agents providing alternative therapeutic approaches to minimize the resistance. These phytoconstituents act in several ways and deliver optimum effectiveness against cancer. Nevertheless, the effectiveness of phyto-formulations in the management of cancers may be constrained due to challenges related to inadequate solubility, bioavailability, and stability. Nanotechnology presents a promising avenue for transforming current… More > Graphic Abstract

M. CAROLINA DI SANTO^1,2,#, AGUSTINA ALAIMO^1,2,#, ANA PAULA DOMÍNGUEZ RUBIO^1,2, OSCAR E. PÉREZ^1,2,*

BIOCELL, Vol.46, No.4, pp. 885-891, 2022, DOI:10.32604/biocell.2022.018391 - 15 December 2021

Abstract Chitosan-based nanocarriers (CS-NCs) show a promising role in improving drugs and bioactive compounds delivery for therapy. However, the effects exerted by CS-NCs at the cellular level, including their recognition and uptake, have not been fully investigated yet. Many factors, including size, shape, concentration, and surface chemistry of CS-NCs, play an important role in determining the types of intracellular signals triggered. The mechanism of uptake and the involvement of the cytoskeleton during the CS-NCs endocytosis variates among the different cell types as well as further effects observed inside cells. In the present work, we discuss the… More >

Xingran Kou^1,2, Qixuan Zhao², Wenwen Xu², Zuobing Xiao², Yunwei Niu², Kai Wang^3,*

Journal of Renewable Materials, Vol.9, No.7, pp. 1189-1211, 2021, DOI:10.32604/jrm.2021.015268 - 18 March 2021

Abstract Several important drugs and nutritional supplements are limited by their lack of bioavailability. Nanomaterials display unique beneficial properties that might help improve the bioavailability of drugs and nutritional supplements. Unfortunately, nanomaterials produced from synthetic polymers and metals may have similar difficulties with bioavailability and toxicity. Naturally occurring biopolymers are biodegradable and non-toxic and are adaptable to the synthesis of nanoparticles. Drugs and other substances can be encapsulated or embedded in such particles with an increase in bioavailability. The search for biodegradable nanomaterials is an active research field. This review summarizes the research on nanocrystalline cellulose, More >